Niche-specific genome degradation and convergent evolution shaping Staphylococcus aureus adaptation during severe infections
Abstract
During severe infections, Staphylococcus aureus moves from its colonising sites to blood and tissues, and is exposed to new selective pressures, thus potentially driving adaptive evolution. Previous studies have shown the key role of the agr locus in S. aureus pathoadaptation, however a more comprehensive characterisation of genetic signatures of bacterial adaptation may enable prediction of clinical outcomes and reveal new targets for treatment and prevention of these infections. Here, we measured adaptation using within-host evolution analysis of 2,590 S. aureus genomes from 396 independent episodes of infection. By capturing a comprehensive repertoire of single-nucleotide and structural genome variations, we found evidence of a distinctive evolutionary pattern within the infecting populations compared to colonising bacteria. These invasive strains had up to 20-fold enrichments for genome degradation signatures and displayed significantly convergent mutations in a distinctive set of genes, linked to antibiotic response and pathogenesis. In addition to agr-mediated adaptation we identified non-canonical, genome-wide significant loci including sucA-sucB and stp1. The prevalence of adaptive changes increased with infection extent, emphasising the clinical significance of these signatures. These findings provide a high-resolution picture of the molecular changes when S. aureus transitions from colonisation to severe infection and may inform correlation of infection outcomes with adaptation signatures.
Data availability
All data generated or analysed during this study are included in the manuscript and supporting file 1-6.The code to call, filter and annotated within-host variants and to perform the enrichment analysis is available on github at https://github.com/stefanogg/staph_adaptation_paper
-
Large tandem chromosome duplications facilitate niche adaptation during persistent infection with drug-resistant Staphylococcus aureusPublicly available at NCBI BioProject (accession no. PRJEB9193).
-
Evolution of Multidrug Resistance during Staphylococcus aureus Infection Involves Mutation of the Essential Two Component Regulator WalKRPublicly available at NCBI Sequencing Read Archive (SRA) (accession no. SRA027352).
-
Evolution of Multidrug Resistance during Staphylococcus aureus Infection Involves Mutation of the Essential Two Component Regulator WalKRPublicly available at NCBI BioProject (accession no. PRJNA29567).
-
Evolution of Multidrug Resistance during Staphylococcus aureus Infection Involves Mutation of the Essential Two Component Regulator WalKRPublicly available at NCBI BioProject (accession no. PRJNA29569).
-
Evolutionary dynamics of Staphylococcus aureus during progression from carriage to disease.Publicly available at NCBI BioProject (accession no. PRJEB2862).
-
Within-host evolution of Staphylococcus aureus during asymptomatic carriage.Publicly available at NCBI BioProject (accession no.PRJEB2881).
-
Development of oxacillin resistance in a patient with recurrent Staphylococcus aureus bacteremia.Publicly available at NCBI BioProject (accession no.PRJNA248678).
-
Population Genomics of Reduced Vancomycin Susceptibility in Staphylococcus aureus.Publicly available at NCBI BioProject (accession no.PRJNA259799).
-
Adaptive processes of Staphylococcus aureus isolates during the progression from acute to chronic bone and joint infections in patients.Publicly available at NCBI BioProject (accession no.PRJNA298748).
-
Severe infections emerge from commensal bacteria by adaptive evolution.Publicly available at NCBI BioProject (accession no.PRJEB2862).
-
Emergence and Within-Host Genetic Evolution of Methicillin-Resistant Staphylococcus aureus Resistant to Linezolid in a Cystic Fibrosis Patient.Publicly available at NCBI BioProject (accession no.PRJNA434495).
-
In vivo competition and horizontal gene transfer among distinct Staphylococcus aureus lineages as major drivers for adaptational changes during long-term persistence in humans.Publicly available at NCBI BioProject (accession no.PRJEB22600).
-
Genome Plasticity of agr-Defective Staphylococcus aureus during Clinical Infection.Publicly available at NCBI BioProject (accession no.PRJNA393749).
-
Genomic exploration of sequential clinical isolates reveals a distinctive molecular signature of persistent Staphylococcus aureus bacteraemia.Publicly available at NCBI BioProject (accession no.PRJEB27932).
-
Genomic evolution of Staphylococcus aureus isolates colonizing the nares and progressing to bacteremia.Publicly available at NCBI BioProject (accession no.PRJNA414752).
-
Mutation of Agr Is Associated with the Adaptation of Staphylococcus aureus to the Host during Chronic Osteomyelitis.Publicly available at NCBI BioProject (accession no.PRJNA414566).
-
The Microevolution and Epidemiology of Staphylococcus aureus Colonization during Atopic Eczema Disease Flare.Publicly available at NCBI BioProject (accession no.PRJEB20148).
-
Chronic Staphylococcus aureus Lung Infection Correlates With Proteogenomic and Metabolic Adaptations Leading to an Increased Intracellular Persistence.Publicly available at NCBI BioProject (accession no.PRJNA446073).
-
Staphylococcus aureus Small Colony Variants (SCVs): News From a Chronic Prosthetic Joint Infection.Publicly available at NCBI BioProject (accession no.PRJNA497214).
-
IS256-Mediated Overexpression of the WalKR Two-Component System Regulon Contributes to Reduced Vancomycin Susceptibility in a Staphylococcus aureus Clinical Isolate.Publicly available at NCBI BioProject (accession no.PRJDB8056).
-
Long-Term Intrahost Evolution of Methicillin Resistant Staphylococcus aureus Among Cystic Fibrosis Patients With Respiratory Carriage.Publicly available at NCBI BioProject (accession no.PRJNA527261).
-
Genomic characterization of inpatient evolution of MRSA resistant to daptomycin, vancomycin and ceftaroline.Publicly available at NCBI BioProject (accession no.PRJNA488707).
-
In-Host Evolution of Daptomycin Resistance and Heteroresistance in Methicillin-Resistant Staphylococcus aureus Strains From Three Endocarditis Patients.Publicly available at NCBI BioProject (accession no.PRJNA577181).
-
Distinct Subpopulations of Intravalvular Methicillin-Resistant Staphylococcus aureus with Variable Susceptibility to Daptomycin in Tricuspid Valve Endocarditis.Publicly available at NCBI BioProject (accession no.PRJNA544229).
-
Safety of bacteriophage therapy in severe Staphylococcus aureus infection.Publicly available at NCBI BioProject (accession no.PRJNA541589).
Article and author information
Author details
Funding
National Health and Medical Research Council
- Timothy P Stinear
National Health and Medical Research Council
- Benjamin P Howden
The University of Melbourne
- Stefano G Giulieri
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Reviewing Editor
- Bavesh D Kana, University of the Witwatersrand, South Africa
Ethics
Human subjects: Ethics approval was obtained at each partecipating site to the CAMERA2 trial and written informed onsent was obtained from each participant or surrogate decision maker.
Version history
- Received: January 19, 2022
- Preprint posted: February 12, 2022 (view preprint)
- Accepted: June 8, 2022
- Accepted Manuscript published: June 14, 2022 (version 1)
- Version of Record published: July 8, 2022 (version 2)
Copyright
© 2022, Giulieri et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 2,336
- views
-
- 530
- downloads
-
- 20
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Evolutionary Biology
- Genetics and Genomics
A protein’s genetic architecture – the set of causal rules by which its sequence produces its functions – also determines its possible evolutionary trajectories. Prior research has proposed that the genetic architecture of proteins is very complex, with pervasive epistatic interactions that constrain evolution and make function difficult to predict from sequence. Most of this work has analyzed only the direct paths between two proteins of interest – excluding the vast majority of possible genotypes and evolutionary trajectories – and has considered only a single protein function, leaving unaddressed the genetic architecture of functional specificity and its impact on the evolution of new functions. Here, we develop a new method based on ordinal logistic regression to directly characterize the global genetic determinants of multiple protein functions from 20-state combinatorial deep mutational scanning (DMS) experiments. We use it to dissect the genetic architecture and evolution of a transcription factor’s specificity for DNA, using data from a combinatorial DMS of an ancient steroid hormone receptor’s capacity to activate transcription from two biologically relevant DNA elements. We show that the genetic architecture of DNA recognition consists of a dense set of main and pairwise effects that involve virtually every possible amino acid state in the protein-DNA interface, but higher-order epistasis plays only a tiny role. Pairwise interactions enlarge the set of functional sequences and are the primary determinants of specificity for different DNA elements. They also massively expand the number of opportunities for single-residue mutations to switch specificity from one DNA target to another. By bringing variants with different functions close together in sequence space, pairwise epistasis therefore facilitates rather than constrains the evolution of new functions.
-
- Genetics and Genomics
Uncovering the regulators of cellular aging will unravel the complexity of aging biology and identify potential therapeutic interventions to delay the onset and progress of chronic, aging-related diseases. In this work, we systematically compared genesets involved in regulating the lifespan of Saccharomyces cerevisiae (a powerful model organism to study the cellular aging of humans) and those with expression changes under rapamycin treatment. Among the functionally uncharacterized genes in the overlap set, YBR238C stood out as the only one downregulated by rapamycin and with an increased chronological and replicative lifespan upon deletion. We show that YBR238C and its paralog RMD9 oppositely affect mitochondria and aging. YBR238C deletion increases the cellular lifespan by enhancing mitochondrial function. Its overexpression accelerates cellular aging via mitochondrial dysfunction. We find that the phenotypic effect of YBR238C is largely explained by HAP4- and RMD9-dependent mechanisms. Furthermore, we find that genetic- or chemical-based induction of mitochondrial dysfunction increases TORC1 (Target of Rapamycin Complex 1) activity that, subsequently, accelerates cellular aging. Notably, TORC1 inhibition by rapamycin (or deletion of YBR238C) improves the shortened lifespan under these mitochondrial dysfunction conditions in yeast and human cells. The growth of mutant cells (a proxy of TORC1 activity) with enhanced mitochondrial function is sensitive to rapamycin whereas the growth of defective mitochondrial mutants is largely resistant to rapamycin compared to wild type. Our findings demonstrate a feedback loop between TORC1 and mitochondria (the TORC1–MItochondria–TORC1 (TOMITO) signaling process) that regulates cellular aging processes. Hereby, YBR238C is an effector of TORC1 modulating mitochondrial function.